相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases
Garrett M. Nash et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
KRAS Mutation and Microsatellite Instability: Two Genetic Markers of Early Tumor Development That Influence the Prognosis of Colorectal Cancer
Garrett M. Nash et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy
Ahmad D. Siddiqui et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications
Antoine Italiano et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Combined analysis of specific KRAS mutation, BRAF and microsatellite instability identifies prognostic subgroups of sporadic and hereditary colorectal cancer
Inti Zlobec et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma
Xiaolong Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans
Krishan Kumar et al.
CLINICAL CANCER RESEARCH (2009)
BRAF Mutation in Papillary Thyroid Carcinoma in a Japanese Population: Its Lack of Correlation with High-Risk Clinicopathological Features and Disease-Free Survival of Patients
Yasuhiro Ito et al.
ENDOCRINE JOURNAL (2009)
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Shuji Ogino et al.
GUT (2009)
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
Susan D. Richman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer
Salvatore Siena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Genetic prognostic and predictive markers in colorectal cancer
Axel Walther et al.
NATURE REVIEWS CANCER (2009)
Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype
Dallas R. English et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
Ludovic Barault et al.
CANCER RESEARCH (2008)
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer
Amy J. French et al.
CLINICAL CANCER RESEARCH (2008)
Asia Pacific consensus recommendations for colorectal cancer screening
J. J. Y. Sung et al.
GUT (2008)
PIK3CA cancer mutations display gender and tissue specificity patterns
Silvia Benvenuti et al.
HUMAN MUTATION (2008)
Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
Ludovic Barault et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
BRAFV600E mutation and outcome of patients with papillary thyroid carcinoma:: A 15-year median follow-up study
Rossella Elisei et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer:: Results from the Netherlands Cohort Study
M. P. Weijenberg et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2008)
Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation
Sun Lee et al.
PATHOLOGY INTERNATIONAL (2008)
BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAFV600E but not KRAS mutations
A. Preto et al.
JOURNAL OF PATHOLOGY (2008)
Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans
Daniel W. Rosenberg et al.
CANCER RESEARCH (2007)
Role of the BRAF mutations in the microsatellite instability genetic pathway in sporadic colorectal cancer
M. L. Maestro et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
J. R. Jass
HISTOPATHOLOGY (2007)
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer
Wade S. Samowitz et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Tracing origin of serrated adenomas with BRAF and KRAS mutations
EJ Lee et al.
VIRCHOWS ARCHIV (2005)
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers
WS Samowitz et al.
CANCER RESEARCH (2005)
Prognostic significance of microsatellite instability and ki-ras mutation type in stage II colorectal cancer
C Wang et al.
ONCOLOGY (2003)
Tumorigenesis -: RAF/RAS oncogenes and mismatch-repair status
H Rajagopalan et al.
NATURE (2002)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
Different mechanisms in the tumorigenesis of proximal and distal colon cancers
A Lindblom
CURRENT OPINION IN ONCOLOGY (2001)
分享论文
